These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 25987325

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Selective Serotonin-norepinephrine Re-uptake Inhibition Limits Renovas-cular-hypertension Induced Cognitive Impairment, Endothelial Dysfunction, and Oxidative Stress Injury.
    Singh P, Sharma B.
    Curr Neurovasc Res; 2016; 13(2):135-46. PubMed ID: 26915517
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. A study of brain insulin receptors, AChE activity and oxidative stress in rat model of ICV STZ induced dementia.
    Agrawal R, Tyagi E, Shukla R, Nath C.
    Neuropharmacology; 2009 Mar; 56(4):779-87. PubMed ID: 19705549
    [Abstract] [Full Text] [Related]

  • 49. Melatonin receptor and KATP channel modulation in experimental vascular dementia.
    Singh P, Gupta S, Sharma B.
    Physiol Behav; 2015 Apr 01; 142():66-78. PubMed ID: 25659733
    [Abstract] [Full Text] [Related]

  • 50. Effects of alpha-lipoic acid on spatial learning and memory, oxidative stress, and central cholinergic system in a rat model of vascular dementia.
    Zhao RR, Xu F, Xu XC, Tan GJ, Liu LM, Wu N, Zhang WZ, Liu JX.
    Neurosci Lett; 2015 Feb 05; 587():113-9. PubMed ID: 25534501
    [Abstract] [Full Text] [Related]

  • 51. Possible role of endothelin receptor against hyperhomocysteinemia and β-amyloid induced AD type of vascular dementia in rats.
    Singh M, Prakash A.
    Brain Res Bull; 2017 Jul 05; 133():31-41. PubMed ID: 28274813
    [Abstract] [Full Text] [Related]

  • 52. Amelioration of intracerebroventricular streptozotocin induced cognitive dysfunction and oxidative stress by vinpocetine -- a PDE1 inhibitor.
    Deshmukh R, Sharma V, Mehan S, Sharma N, Bedi KL.
    Eur J Pharmacol; 2009 Oct 12; 620(1-3):49-56. PubMed ID: 19699735
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Modulation of celecoxib- and streptozotocin-induced experimental dementia of Alzheimer's disease by pitavastatin and donepezil.
    Sharma B, Singh N, Singh M.
    J Psychopharmacol; 2008 Mar 12; 22(2):162-71. PubMed ID: 18208924
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Protective effects of phosphodiesterase-1 (PDE1) and ATP sensitive potassium (KATP) channel modulators against 3-nitropropionic acid induced behavioral and biochemical toxicities in experimental Huntington׳s disease.
    Gupta S, Sharma B.
    Eur J Pharmacol; 2014 Jun 05; 732():111-22. PubMed ID: 24690258
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.